• 1. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 2. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 3. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 4. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 5. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan

Comprehensive Overview of 2-Bromo-5-(bromomethyl)-3-methylpyridine (CAS No. 1805103-19-8)

2-Bromo-5-(bromomethyl)-3-methylpyridine (CAS No. 1805103-19-8) is a highly versatile brominated pyridine derivative that has garnered significant attention in pharmaceutical and agrochemical research. This compound, characterized by its unique molecular structure featuring both bromomethyl and methyl substituents, serves as a critical intermediate in the synthesis of complex organic molecules. Its pyridine backbone, combined with strategic halogenation, makes it a valuable building block for drug discovery and material science applications.

In recent years, the demand for brominated pyridine derivatives like 2-Bromo-5-(bromomethyl)-3-methylpyridine has surged due to their role in developing small-molecule inhibitors and biologically active compounds. Researchers are particularly interested in its potential applications in kinase inhibitor synthesis, a hot topic in oncology and autoimmune disease research. The compound's dual bromine functionality allows for selective cross-coupling reactions, enabling the creation of diverse molecular architectures with high precision.

From a synthetic chemistry perspective, CAS No. 1805103-19-8 offers exceptional reactivity in palladium-catalyzed couplings, such as Suzuki-Miyaura and Buchwald-Hartwig reactions. This aligns with the growing trend toward green chemistry, as these methods often reduce waste and improve atom economy. The compound's stability under various reaction conditions also makes it a preferred choice for high-throughput screening libraries, addressing the pharmaceutical industry's need for efficient lead optimization.

Beyond pharmaceuticals, 2-Bromo-5-(bromomethyl)-3-methylpyridine has shown promise in agrochemical innovation. Its structural motifs are being explored for designing next-generation crop protection agents, particularly in addressing resistance issues in pest management. The methylpyridine core contributes to enhanced bioavailability, a key consideration in modern pesticide development.

Analytical studies of this compound highlight its compatibility with advanced chromatographic techniques, including HPLC and LC-MS, which are essential for quality control in industrial-scale production. The rise of continuous flow chemistry has further amplified interest in such brominated intermediates, as they enable safer handling and improved scalability compared to traditional batch processes.

As the scientific community continues to explore structure-activity relationships (SAR) in medicinal chemistry, 2-Bromo-5-(bromomethyl)-3-methylpyridine remains at the forefront due to its balanced lipophilicity and steric properties. Its molecular weight (265.94 g/mol) and logP value make it particularly suitable for CNS-targeting drug candidates, a rapidly growing segment in neuropharmacology research.

Environmental considerations surrounding brominated compounds have led to increased scrutiny of their ecological impact. However, 1805103-19-8 demonstrates favorable biodegradation profiles in preliminary studies, positioning it as a more sustainable option compared to persistent halogenated analogs. This aspect resonates with current industry priorities for eco-friendly chemical solutions.

The compound's crystalline form and well-defined melting point (reported between 85-88°C) facilitate purification processes, addressing common challenges in high-purity intermediate production. These characteristics are particularly valuable for GMP-compliant synthesis in regulated industries, where consistency and reproducibility are paramount.

Emerging applications in material science have revealed that 2-Bromo-5-(bromomethyl)-3-methylpyridine can serve as a precursor for functionalized polymers with tailored electronic properties. This expands its relevance beyond life sciences into areas like organic electronics and conductive materials, demonstrating the compound's multidisciplinary utility.

In conclusion, CAS No. 1805103-19-8 represents a strategically important chemical entity that bridges multiple scientific domains. Its unique combination of reactivity, stability, and structural versatility ensures its continued relevance in cutting-edge research and industrial applications. As synthetic methodologies evolve and new therapeutic targets emerge, this brominated pyridine derivative will undoubtedly play a pivotal role in shaping future innovations across chemistry-driven industries.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)